Inventiva S.A. (EPA:IVA)
4.680
+0.300 (6.85%)
May 25, 2026, 12:45 PM CET
Inventiva Employees
As of December 31, 2025, Inventiva had 77 total employees, including 69 full-time and 8 part-time employees. The number of employees decreased by 41 or -34.75% compared to the previous year.
Employees
77
Change
-41
Growth
-34.75%
Revenue / Employee
€92,616
Profits / Employee
€4,851,205
Market Cap
909.76M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 77 | -41 | -34.75% | 69 | 8 |
| Jun 30, 2025 | 84 | - | - | 84 | 0 |
| Dec 31, 2024 | 118 | -5 | -4.07% | 114 | 4 |
| Dec 31, 2023 | 123 | 10 | 8.85% | 120 | 3 |
| Dec 31, 2022 | 113 | 8 | 7.62% | 109 | 4 |
| Dec 31, 2021 | 105 | 11 | 11.70% | 101 | 4 |
| Mar 31, 2021 | 95 | 7 | 7.95% | 95 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 674 |
| Cellectis | 229 |
| Genfit | 188 |
| Innate Pharma | 164 |
| DBV Technologies | 161 |
| MedinCell | 145 |
| Transgene | 145 |
| Nanobiotix | 100 |
Inventiva News
- 3 days ago - Inventiva to Present at 2026 Jefferies Global Healthcare Conference - GlobeNewsWire
- 12 days ago - Inventiva to Present Abstracts at the EASL Congress 2026 - GlobeNewsWire
- 4 weeks ago - Inventiva (IVA) Enhances Leadership Team with New Appointments - GuruFocus
- 4 weeks ago - Inventiva CFO Jean Volatier to switch roles, Axel-Sven Malkomes to succeed - TheFly
- 4 weeks ago - Inventiva Strengthens Leadership Team Ahead of Expected Phase 3 Data Readout of Lanifibranor - GlobeNewsWire
- 5 weeks ago - Three new option listings and one option delisting on April 15th - TheFly
- 6 weeks ago - Inventiva announces filing of its 2025 Universal Registration Document and 2025 Annual Report on Form 20-F - GlobeNewsWire
- 7 weeks ago - Inventiva price target lowered to $15 from $17 at Stifel - TheFly